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Immunoassay Methods Focus on 
Skeletal Muscle Proteins
Gisela Gaina
Abstract
The skeletal muscle is a complex tissue that represents most of the muscle 
tissue in mammals and plays a key role in health and in the body’s function. It is a 
heterogeneous tissue whose contractile and metabolic functions depend on type, 
size, and quality of a large number of proteins. The multitude of proteins, the 
relationships that exist between them, and functional changes that occur in differ-
ent muscle pathologies make their investigation to be challenged. In this chapter, 
current approaches in proteomic studies, its application, specific technical advice, 
and recent progress of the most important techniques based on antigen-antibody 
interactions used for the analysis of muscle proteins involved in different muscle 
diseases are presented.
Keywords: antigen, antibody, immunofluorescence, western bolt, antisense 
oligonucleotides
1. Introduction
Proteins, key players responsible for good muscle function, are the main struc-
tural and functional constituents of the muscle [1]. In the last three decades, a 
considerable amount of skeletal muscle proteins that present a vast variation in size, 
shape, abundance, and expression have been identified. Based on their localization, 
muscle proteins are grouped as muscle membrane (dystrophin, sarcoglycans, dysfer-
lin, and caveolin-3), the extracellular matrix (a2-laminin and collagen VI) and from 
the sarcomere (telethonin, myotilin, titin, and nebulin), the muscle cytosol (calpain 
3, myotubularin, TRIM32), the nucleus (emerin, lamin A/C, SMN) [2]. Mutation in 
the gene that encodes for specific muscle proteins is responsible for the changes in 
expression of most of them and lead to different forms of neuromuscular diseases.
Evaluation of the localization of a protein on tissue, its expression, cellular level, 
and understanding of the interactions with different other proteins can elucidate 
the molecular basis of muscle pathology.
The differences in terms of size (from titin with a molecular mass around 
1200 kDa, nebulin 700 kDa, to caveolin 3–25 kDa) and location of each of them 
make their investigation difficult [3].
However, the examination of the muscle protein expression by immunostaining 
reactions, as well as investigation of the abundance and size using SDS gel elec-
trophoresis by methods based on antigen-antibody interaction method, has been 
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developed and improved over time [4]. The immunoassay methods represent a pow-
erful tool that offers comprehensive details about the molecular alteration of different 
muscle pathology. Different strategies have improved over time in terms of quality 
and sensitivity, but each of them has the specific requirement as well as limitations.
Applications of immunoassay techniques contribute to both diagnostic and 
research purposes for biomarkers identification and therapeutic drug monitoring.
This chapter presents the most used techniques based on the interaction between 
antibodies (Ab) with a specific antigen (Ag) for muscle protein analysis, providing 
necessary knowledge for obtaining a good result, and provides some suggestions for 
the inherent problems that may be encountered in different stages.
2. Current immunoassay technologies and approaches
Immunoassay methods, technologies based on the properties of the antigen-
antibody interaction, allow both qualitative and quantitative analysis of interest 
protein. Most important and used qualitative methods for the investigation of 
muscle proteins are immunohistochemistry (IHC) and fluorescent immunohisto-
chemistry “gold standard” in muscle biopsy analysis. Their use for the evaluation 
of muscle proteins regarding localization, loss, accumulation, or maldistribution 
of different proteins involved in different myopathies has increased since the 1960s 
[5]. Advances in basic muscle research and development of new antibodies have 
increased the broad diversity of the proteins that can be analyzed. Also, technologi-
cal advances in image capture, as well as improved image analysis software, now 
allow better interpretation and quantification of the protein expression levels both 
for research and for clinical pathological diagnosis. Because the successful outcome 
of IHC depends strictly on choosing a specific and sensitive primary antibody, 
and to avoid possible false-positive results, the need for an alternative method to 
confirm results was imperative [6]. However, for the detection and quantification 
of proteins in complex biological mixtures as well as for confirmation of immuno-
histochemistry results, western blot represents a good alternative. Western blot, 
also known as immunoblot, is an important quantitative method for qualitative and 
semiquantitative sample analysis and differential diagnosis [7].
Both immunoassay methods have various applications and have been widely 
used in the identification of biomarkers, diagnosis of diseases, therapeutic drug 
monitoring, and drug discovery, as well as characterization of protein expression 
and function by use of antibodies (Table 1).
2.1 Antigens and antibodies
2.1.1 Antigens
Antigens, also called immunogens, are any macromolecule of natural or syn-
thetic origin such as proteins, polypeptides, polysaccharides, nucleic acids, and 
infectious agents that stimulate the immune system to induce an immune response 
(e.g., to produce a specific antibody). An antigen (Ag) molecule consists of two 
components: a carrier that is the largest part of the molecule and specific antigenic 
determinants or epitopes that are immunologic active regions of the antigens rec-
ognized by an antibody. An epitope is usually a protein segment by 5 to 8 six amino 
acids in length, specific for each antigen. The fixation of the antigen at the combin-
ing site of the immunoglobulin occurs based on the complementarity between epi-
tope and paratope by multiple noncovalent bonds, van der Waals forces, hydrogen, 
and hydrophobic-type interactions. The rate formation of the antigen-antibody 
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complex depends not only on the preservation and accessibility of epitopes to the 
antibodies [8] as well as the concentration of the reactants but also on the mutual 
affinity. The alteration or destruction of epitopes by different treatment determines 
the reduced or abolished antigen-antibody interaction.
Because proteins are the most powerful antigens, the immunohistochemistry 
reaction is primarily concerned on their identification and localization as well 
as glycoprotein and lipoprotein compounds. The successful rate of immunohis-
tochemistry reaction-detection of the antigen-antibody complex-depends on 
several factors of which the most important are: (i) the reactivity and quality of the 
reagents; (ii) antigen concentration in the analyzed tissue; (iii) antigen retrieval 
methods; and (iv) labeling conditions and methods used [9].
2.1.2 Antibodies
Antibodies also called immunoglobulins (Ig) are large Y-shaped animal glyco-
proteins made up of four polypeptide chains: two identical heavy chains (H) and 
two identical light chains (L) linked together by disulfide bonds.
While there are two main types of light chains kappa (κ) and lambda (λ) that 
decide the type of immunoglobulin molecule, for the heavy chains, 5 isotypes are 
found in the molecule in mammals such as humans and mice and determine the 
class of immunoglobulins: IgG, IgM, IgA, IgD, and IgE, each playing a specific role 
[10]. The main immunoglobulin (Ig) found in human serum that makes up about 
75% of the total immunoglobulins is IgG, which is further divided into four sub-
classes: IgG1, IgG2, IgG3, and IgG4, each with its own biologic properties [10]. IgA 
can be split into two subclasses: IgA1 and IgA2 [11].
Ig is also a bifunctional molecule presenting two antigen-binding sites called Fab 
fragment and one complement-binding site called Fc fragment. For both heavy and 
light chains, the C terminal parts contain constant regions of the antibody, while the 
N-terminal contains variable domain through the antibody that binds to the antigen 
named binding site or paratope. The specificity, affinity, and antibody diversity are 
determined by the structure of this region [12].
Abbreviation Method Relevance to muscle proteomic studies
IHC Immunohistochemistry Localization of a protein
Accumulation of a protein in a tissue
Qualitative pattern: presence, absence, or reduction
Secondary reduction
IF Immunofluorescence Localization of a protein
Accumulation of a protein in a tissue
Qualitative pattern: presence, absence, or reduction
Secondary reduction
ICW In-cell Western Detect and quantify target proteins localized in-cell
Quantitative analysis of cellular signaling pathways
WB Western blot Evaluation of molecular mass and abundance
Differential diagnosis
Level of expression
MWB Multiplex Western blot Localization of a protein
Accumulation of a protein in a tissue
Qualitative pattern: presence, absence, or reduction
Secondary reduction
Table 1. 
Methods and their relevance to proteomic studies.
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The use of antibodies for the identification of protein antigen in human tissue 
was a revolutionary step for methods like western blotting, immunofluorescence, 
and immunohistochemical studies. The two most used types of antibodies in these 
studies are monoclonal and polyclonal antibodies.
For a successful immunohistochemistry experiment, a few things related to 
antibodies must be known such as whether the antibody will react with the antigen 
under conditions of fixation and processing system used, the immunoglobulin class 
to which the antibody belongs, the species in which the antibody was generated, 
which epitope to be targeted, type of antibody used (monoclonal or polyclonal), 
and analysis methods.
2.1.3 Monoclonal versus polyclonal antibodies
Besides the crucial and active role, which it plays in producing the mammal’s 
normal immune response following the action of pathogens, antibodies are power-
ful tools for research and diagnostic purposes. Due to high exquisite specificity and 
selectivity, antibodies are an excellent tool utilized in a wide variety of therapeutic 
applications including detection and quantification of molecules of interest [13].
Antibodies used for research and diagnostic applications are produced by 
repeatedly injecting a laboratory animal (e.g., mice, rats, rabbits, and goats) with 
a specific antigen until it confirms the occurrence of antigen-specific antibodies 
in the blood serum. Generally, based on production and purification methods, 
antibodies can be classified into two groups: polyclonal or monoclonal.
Monoclonal antibodies (mAbs) refer to a specific antibody for a single antigenic 
epitope secreted from a single B-cell plasma clone. Subsequent, B-cells are fused 
with a myeloma cell line and grown in culture.
Polyclonal antibodies (pAbs) are produced by injecting a laboratory animal (e.g., 
mice, rats, rabbits, and goats) with a specific antigen and are a heterogeneous mix-
ture of immunoglobulin molecules that are usually produced by different B-cell clone 
species. They can recognize and bind to several antigenic epitopes of a single antigen.
For the identification of the same antigen, both monoclonal and polyclonal anti-
bodies are available. Choosing a primary monoclonal or polyclonal antibody for a 
specific target in immunoassay methods depends on the purpose of the experiment.
In the immunostaining methods based on antigen-antibody interaction, higher 
specificity and lower affinity of the mAbs as well as lower specificity but higher 
affinity of pAbs must be taken into account. To assess changes in molecular confor-
mation, protein-protein interactions, as well as to identify the members of protein 
families, mAbs are more useful because of their monospecificity [14]. Polyclonal 
antibodies prove their usefulness in the studies they are aiming to detect variants 
of a particular protein of interest [15] by being able to amplify the signal of interest 
protein with low expression level (Table 2).
2.1.4 The characteristics of antibody-antigen interaction
Antigen-antibody complex (immune complex) is a bimolecular association that 
occurs when an antigen combines with an antibody based on the affinity of the 
antibody for the antigen. The reaction of the antibody-antigen is highly specific. 
The antibodies recognize the epitope region of the antigens and interaction between 
them is maintained due to exclusively noncovalent bonds such as hydrogen bonds, 
ionic bonds, hydrophobic interactions, and van der Waals forces [16]. The bonds are 
irreversible, but the antigen-antibody interaction can be affected during wash-
ing steps leading to dissociation of the complex. A lot of factors can influence the 
Ag-Ac complex such us temperature of incubation, pH buffer, the concentration of 
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antigen/antibody, and incubation time as well as the number of antigen sites per cell 
(zygosity) [16, 17].
2.1.5 Detection systems
The Ag-Ab complexes are not visible with standard microscopy and must be 
labeled. A wide range of fluorochromes is commercially available. An important 
property of a fluorochrome is the absorption spectrum. Fluorochromes absorb light 
at one wavelength [18] and emit light at a different wavelength.
The most commonly used markers for labeling are:
a. Fluorochromes: mostly used are fluorescein (absorbs blue light and emits 
yellow-green) and rhodamine (absorbs yellow-green light and emits deep red)
b. Enzymes for histochemical techniques (e.g., peroxidase, alkaline phosphatase, 
and glucose oxidase)
c. Metals for use in electron microscopy (ferritin and colloidal gold)
Most often, the sensitivity of an immunolabeling reaction depends on the 
selection of the detection system, which makes the choice of detection to be done 
carefully. The permanent attempt to obtain better results and significant advances 
in the biology field has led to the development of numerous methods for visualizing 
the antibody-antigen complex. Detection systems are classified as direct or indirect 
methods depending upon whether the fluorochrome is attached to the primary, 
secondary, or tertiary antibody. Regardless of the method chosen for labeling, both 
direct and indirect assay make possible distribution and precise localization of a 
specific protein or specific cellular components within a tissue or cell as well as the 
study of protein expression and function (Table 3).
2.1.5.1 Direct labeling
The direct labeling method is used for the detection of the point of interest in 
a specimen using a single primary Ab directly coupled with a reporter molecule 
(Figure 1). The method is usually shorter, involves one incubation step reaction, 
Monoclonal antibodies Polyclonal antibodies
Advantages Higher specificity to a single 
epitope
Higher reproducibility
Moderate sensitivity
Reduced cross-reactivity
Provide better results
Rapid generation and less expense costs
Higher affinity–recognize and bind to many 
different epitopes of a single antigen
Less technical skill required for production
Easy to store
Quicker binding to the target antigen
Stable to pH and buffer conditions
Disadvantages More time − 4-6 months to 
produce and develop
Expensive costs for production
Less tolerance to pH and buffer 
condition changes
Cross-reactivity due to a recognition of multiple 
epitopes
High variability between different lots produced 
in different animals at different times
“Sensitivity” refers to the limit of detection of an assay for a specific target in a sample.
“Specificity” refers to the ability of a method to measure a specific target in a sample.
Table 2. 
Characteristics of monoclonal and polyclonal antibodies.
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and is widely used for detecting highly expressed antigens in a tissue. The advan-
tage of the direct labeling method is the avoidance of antibody cross-reactivity or 
nonspecificity.
Nevertheless, direct labeling is not routinely employed in clinical and research 
applications due to insufficient sensitivity of the method in detecting of antigens in 
a tissue, the weak intensity of obtained signal, as well as optimal given preparation 
process of attaching fluorochrome to the antibody, which can affect antibody affin-
ity. To date, for muscle protein analysis is used indirect labeling due to the higher 
sensitivity of the method.
2.1.5.2 Indirect labeling
The need to improve the sensitivity of detection methods of antigens with low 
expression led to the development of labeling methods in several stages, which 
intensifies the signal. Coons et al. developed in 1941 a detection method that 
involved two distinct steps: i) an unconjugated primary antibody incubated with 
tissue section that binds to the target molecule and forms an invisible antigen-
antibody complex and ii) secondary antibody, which carries the fluorophores, 
enzyme, and biotin, recognizes, and binds to the primary antibody facilitating 
Figure 1. 
Schematic representation of immunolabeling mechanisms. (1) Direct labeling; (2) Indirect labeling with 
secondary antibody conjugate with fluorophore; (3) indirect labeling with biotinylated secondary antibody.
Direct Indirect
Advantages Single labeling step
Short time procedure
No cross-species reactivity
Great sensitivity-high amplification of the 
signal
Production of the secondary antibodies is 
inexpensive
Disadvantages Less sensitivity
Lower signal
Higher costs
Restricted availability of direct 
conjugate antibodies
Double labeling steps
Long procedure
Extra incubation and wash steps are 
required
High background due to endogenous 
activity
Table 3. 
Advantage and disadvantage of immunofluorescence methods.
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detection by producing a fluorescent signal or a collared substance. This method 
was a progress for labeling method because it allowed the amplification of the 
signal by increasing the number of fluorophore molecules that target the antigen. 
There are several advantages of the method that make it so popular: different 
primary antibodies can be used with the same secondary antibody, the possibility 
of use of secondary antibodies conjugated with different dye fluorophores, and 
the ability of the unconjugated primary antibody to bind to up to five secondary 
antibodies [19].
Thus, the indirect method is no longer used in its original form but continues 
to develop both the identification and production of a large number of fluorescent 
molecules, as well as the improvement of specific methodologies for coupling 
fluorochromes with antibodies.
2.1.6 Important parameters for immunomarkers
Therefore, even the immunostaining methods may seem simple in concept, 
there are many critical steps in performing it. To ensure success and to obtain good 
results, several parameters should be considered as follows:
1. Sample collection and tissue handling immediately after surgery play an 
important role in immunostaining. For example, [20] showed that a long time 
after harvesting increases degradation of calpain 3 in muscle due to autolysis 
that can affect the detection of this protein involved in a type of muscular dys-
trophy by immunostaining methods.
2. Specimen fixation is another important step in immunostaining. The altera-
tion, damage, or maskings of the epitope of some antibodies against sarcolem-
mal membrane-associated proteins by fixation in formalin-fixed and paraffin-
embedded skeletal muscle tissue have been reported [21].
3. Slide storage conditions: Following freezing and until sectioning, tissue must 
be stored at ultra-low temperature (−80°C). The tissue architecture undergoes 
damage due to freeze-thaw [22]. Also, longer storage tissue sections lead to 
cracking as well as decrease in intensity signal levels. Furthermore, protecting 
the tissue slide from oxidation must be considered.
4. Probe size: Depending on the purpose, the tissue section for immunostaining 
can vary. Previous reports have shown that the intensity of staining is indeed 
dependent on tissue thickness [23]. Generally, for muscle protein analysis, the 
recommended thickness of tissue slides is 7um for tissue cryosection […] and 
3–5 μm for FFPE sections [21].
5. Antibody selection (monoclonal vs polyclonal): This step is critical for immu-
nostaining methods. Knowing the differences between monoclonal antibodies 
(that recognize a single epitope in an antigen) and polyclonal antibodies (that 
bind to multiple different epitopes from an antigen) for the interest target 
must be selected the antibodies with higher specificity. In addition, antibody 
concentration, working temperature, and duration of incubation affects the 
immunostaining reaction results and must be optimized.
6. Controls: Due to insufficient specificity of antibodies or procedures used, 
sometimes unexpected binding and labeling can occur. To avoid confusing or 
inconsistent obtained results as well as to demonstrate that the detected signal 
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is specific for the target protein, a set of controls is required to demonstrate the 
reliability of labeling. Therefore, while planning immunolabeling experiment, 
more types of controls are essential [24] and should be included to validate the 
staining reaction and to show that the protocol works properly:
Tissue (antigen) controls
• Positive control: a tissue section, which is known to express the target protein; 
successful staining reactions of this control demonstrate the protocol and 
parameters used to detect the target protein.
• Negative control: a tissue section known not expressed the target protein and no 
response is expected. It is useful for the identification of positive errors.
• Tissue background control: used to avoid interpretation of autofluorescence 
mainly comes from mitochondria, lysosomes, for example, as positive results.
Reagent specificity controls
• Primary antibody controls: useful to demonstrate specific binding of the 
primary antibody to the antigen
• Secondary antibody controls: useful to show specific binding of the secondary 
antibody to the primary antibody
The use of antibodies in immunohistochemical microscopy-based experi-
ments is a helpful tool for identification, localization, and expression patterns of 
muscle proteins. This technique is still routinely used in research to study the role 
of interest protein both in healthy and in pathological muscle as well as for diag-
nostic purposes or optimized treatment regimes and therapeutic drug monitoring. 
However, the use of one method only for the complete characterization of a muscle 
protein is not enough. The advances in the proteomic field led to the improvement 
of the analytical method for identification and quantification of proteins avoiding 
thus inconsistent and confusing immunocytochemical results.
The most used method for confirmation of immunohistochemical results as well 
as for the size of the protein is western blot. There are many different types and 
methods for Western blotting.
2.2 Western blot
The Western blot (WB) method also known as protein immunoblotting is an 
important analytical and quantitative technique used to identify, to separate a 
specific protein from a given complex biological mixture of proteins from a tis-
sue/cellular homogenate, and to determine the amount of antigens (proteins) in 
reaction with a specific antibody. Initially, the proteins are electrophoretically 
separated into a polyacrylamide (PAA) gel electrophoresis. The most widely used 
technique for large scale protein from a mixture of proteins is sodium dodecyl 
sulfate polyacrylamide gel electrophoresis (SDS-PAGE) due to the possibility of 
separation of proteins based on their molecular weight under the action of electric 
current after linearization of the proteins. Special gradient gels are used to separate 
proteins with a wide variety of molecular mass. After the separation, the proteins 
are electrophoretically transferred on a solid substrate such as nitrocellulose, PVDF, 
or cationic nylon membrane. To suppress nonspecific adsorption of the antibodies, 
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the unreacted nonreactive binding sites on the membrane are blocked, which causes 
immobilized proteins to react specifically with monoclonal or polyclonal antibod-
ies. Primary antibodies can be applied single when we target the expression of a 
single protein or in a cocktail when a simultaneous analysis of several proteins is 
necessary. Commonly used conjugates for secondary antibody are color, radioactiv-
ity, enzyme, as well as biotin. Antigen-antibody complexes are radiographically, 
chromogenically, or chemiluminescently visualized.
With this technique, the size (molecular mass) and abundance of the interest 
protein are evaluated by comparing with the control. The need for the analyses 
of multiple different target proteins simultaneously led to great improvement of 
sample separation resolution.
2.2.1 Multiplex Western blot
The multiplex detection methods have improved over the past few decades and 
have led from the analysis of a single specific protein to the detection of simultane-
ously multiple target proteins with a different molecular weight in a complex of 
cellular homogenates [25, 26]. For the simultaneous analysis of muscle proteins, a 
biphasic polyacrylamide gel system with different concentrations is used. With this 
system, the separation of muscle proteins is done based on their molecular weight 
(proteins with molecular weight more than 200 kDa are separate in the top part of 
the gel, e.g., dystrophin, while the smaller proteins under 150 kDa, e.g., calpain 3 in 
the bottom). Highlighting of proteins is achieved with a cocktail of specific primary 
antibodies.
Simultaneous analysis of multiple proteins involved in different muscle patholo-
gies revolutionized the medical diagnosis, reduced cost and time for analysis, and 
improved differential diagnosis in muscle pathology.
2.2.2 In-cell western (ICW) assay
ICW also known as in-cell ELISA (ICE) is quite a novel quantitative immunoflu-
orescence-based technique suitable for the detection of protein levels and signaling 
events performed in cell culture grown on microplate format [27]. It is an extremely 
sensitive method and accurately quantifies, which can detect two targets normally 
labeled with specific primary antibody followed by incubation with secondary 
antibody fluorescent conjugated with spectrally distinct dyes and quantification of 
the signals from fluorophores conjugated at different wavelengths on two detec-
tion channels. The technique allowed the quantification of proteins directly in cell 
culture [28]. The accuracy of quantification is increased by normalization due to 
adjustments of the cell number in wells. This technique is also useful in the study of 
the drug effect on multiple points.
2.3 Data acquisition and image analysis
For the evaluation of antigen expression by immunohistochemistry (IHC) and 
fluorescent IHC, a comprehensive microscopic evaluation of the signal beside speci-
men preparation and staining protocol depends also on the type of microscope used 
for acquisition of imagines.
2.3.1 Light microscopy
In bright-field microscopic IHC, antigen expression in muscle is visualized by a 
combination of a secondary antibody with an enzyme and utilizing a colorimetric 
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substrate that produces a colored reaction product detected by light microscopy. 
The most widely used enzymes in chromogenic detection are the horseradish 
peroxidase (HRP) and alkaline phosphatase (AP), which convert 3,3′ diaminoben-
zidine (DAB) and 3-amino-9-ethylcarbazole (AEC) into brown and red end color, 
respectively. The reaction product is stable for a long time and visualization can 
be done any time. Multiple labeling is also possible since different substrates are 
now available for the same enzyme, but low contrast and resolution for samples is a 
limitation of bright-field microscopy.
2.3.2 Fluorescent microscopy
Although a lot of muscle proteins can be detected by IHC with peroxidase 
and visualized in light microscope field, the labeling of antigen with an antibody 
coupled with a fluorochrome permitted a superior viewing of many muscle pro-
teins and offered significant advantages in accurately identifying certain protein 
localizations and distinguishing subtle difference in protein expression patterns. 
The major advantage of fluorescence microscopy is given with the possibility of 
uses of different dyes that span the entire visible spectrum to track different target 
proteins. Also, the identification of the interaction between proteins as well as 
their specific localization is better observed by colocalization when the color of 
two or more different fluorescent dyes used appears changed as a result of the 
overlap. One limitation of fluorescence microscopy remains the loss of the fluores-
cent capacity of fluorophores (photobleaching) due to many cycles of excitation 
and emission [29]. Therefore, it is recommended to keep the samples marked in 
dark when not in use and use a mounting medium with an antifade agent to fix this 
problem.
In combination with laser confocal scanning microscope, fluorescence is prefer-
able to evaluate the degree of colocalization and relative quantitation of proteins by 
specialized software [30].
2.3.3 Confocal microscopy
Confocal microscopy is a powerful laser scanning method used for the imaging 
analysis of fluorescently labeled specimens.
The technique provides high-resolution detailed information about the 3D struc-
ture of the tissue sections and cells allowing detailed analyses and measurements 
of double, triple, and even quadruple stained sections [31, 32]. This is possible due 
to labeling of secondary antibodies with different fluorophores, which emitted on a 
different wavelength.
The z-stack mode permitted three-dimensional reconstructions of optical 
sectioning useful for the study of the relationship between stained structures.
2.4 Qualitative and quantitative analysis of proteins
Muscle pathology usually involves changes in level and protein expression. For 
muscle protein diagnosis, a good knowledge is required of the expected cellular 
location: at sarcolemmal level (dystrophin, sarcoglycans, dysferlin, and caveolin-3), 
in the cytoplasm (calpain 3 and TRIM32), and nuclear (emerin and lamin A/C) 
level. The initial choice of a qualitative or quantitative method for protein analysis 
depends on the availability of the methods and the specificity of the antibodies. It 
should be mentioned that the results obtained by one method have to be confirmed 
by another; see Table 4.
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Disease Gene Primary 
protein defect
Secondary changes Localization 
level
Clue to diagnosis References
IF/WB
DMD DMD Dystrophin Utrophin upregulated Sarcoglycans 
reduced/absent Dystroglycan reduced/
absent
nNOS absent
Subsarcolemmal Absent, reduced/absent [2, 43]
BMD DMD Dystrophin Utrophin upregulated
Sarcoglycans reduced/absent 
Dystroglycan reduced/absent
nNOS reduced/absent
Subsarcolemmal Reduced/Reduced in size/amount
Absence of at least one antibody
[2, 43]
DMD/
BMD carriers
DMD Dystrophin Utrophin upregulated
Sarcoglycans reduced/absent
Dystroglycan reduced/absent
nNOS may be absent
Subsarcolemmal Mosaic pattern/ Reduced in size [2, 43]
LGMD2C-F SGCG 
SGCA
SGCB
SGCD
Sarcoglycans Reduction of other sarcoglycan
Β-Dystroglycan reported
Possible reduction Dystrophin
Loss of nNOS reported
Sarcolemmal Variably reduction/absent [44]
LGMD2B DYSF Dysferlin Caveolin-3 reduced Sarcolemmal Absent/reduced [45]
LGMD1C CAV3 Caveolin-3 Dysferlin reduced Sarcolemmal Absent/reduced [45]
CMD LAMA2 Laminin α2 Deficiencies of laminin β2,
α-dystroglycan and integrin α7
Extracellular 
matrix
Completely or partially absent [46]
Bethlem or 
Ullrich myopathy
Collagen VI Deficiency of laminin β1 chain Extracellular 
matrix
Reduced/absent [47]
LGMD2G TCAP Telethonin — Sarcomere Reduced/absent [44, 48]
LGMD2J TTN Titin Calpain 3 reduction Sarcomere Absence of calpain 3/loss of C-terminal 
fragments of titin results in the 
reduction of higher molecular weight
[48, 49]
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Disease Gene Primary 
protein defect
Secondary changes Localization 
level
Clue to diagnosis References
IF/WB
LGMD1A MYOT Myotilin Secondary laminin γ reduction Sarcomere Protein aggregates [45, 48]
LGMD 1E DES Desmin Myotilin, αB-crystallin, VCP 
cytoplasmic aggregates
Exosarcomeric Desmin cytoplasmic aggregates [50]
LGMD2A CAPN3 Calpain 3 Dysferlin reduced Cytosol Labeling may be absent or reduced on 
sections/
Calpain 3 bands may be variably 
reduced
[44, 50]
LGMD 2H TRIM32 Trim 32 — Cytosol Reduced expression/reduced level [51]
Emery-Dreifuss 
MD
EMD Emerin — Nucleus Absent /reduced level [52]
LGMD1B LMNA Lamin A/C Laminin β1 reduction Nucleus Lamin A/C normally expressed [44]
Table 4. 
The skeletal muscle-specific proteins.
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2.4.1 Analysis of immunohistochemical expression
Immunohistochemical staining is useful for the identification of the interest 
markers and provides valuable information about their distribution, localization, 
and expression in a tissue or cell. The obtained results should be interpreted by 
comparing a given protein pattern in normal and affected tissue in the presence 
of the controls of the reaction mentioned above. The evaluation of muscle protein 
expression is generally made in a qualitative manner based on their presence, 
absence, or variable reduction. Depending on the manifestation of the protein 
identified by immunohistochemical analysis, the progression of different neuro-
muscular disorders can be evaluated.
The usefulness of the method lies in the identification of the primary protein 
abnormalities in recessive diseases [33] and secondary reduction of interconnected 
proteins. For example, in the primary reduction of dystrophin, protein involved in 
Duchenne/Becker muscular dystrophy and secondary reduction of sarcoglycans 
[22] and of cytosolic calpain 3 [25] was reported. The reduction of dysferlin also is 
accompanied by the reduction of calpain 3.
Because of the currently limited access to next-generation sequencing that 
permitted analysis of simultaneous gene involved in a different type of muscular 
dystrophies, analysis of muscle biopsy by the immunoassay method is still a helpful 
method in many laboratories. Different computational methods developed in the 
last decade for quantitative immunohistochemical (IHC) image analysis of proteins 
have begun to be increasingly used.
How much protein is needed for proper muscle function has always been a prob-
lem that researchers have been trying to solve. Immunohistochemistry quantifica-
tion of dystrophin proteins involved in the most severe type of muscular dystrophy 
has come to the attention of researchers with the improvement of image analysis 
software. Thus, L. E. Taylor [34] and Antony K [35] developed a method of image 
analysis that allows immunofluorescent quantification of dystrophin expression in 
sections that proved to be robust and reliable method of biomarker detection. These 
methodologies contribute to and improve the final diagnosis and especially are used 
in the analysis of a protein after a drug and specific treatment.
However, increasing the contradictory results obtained by this method and 
reported in the literature, a final and accurate diagnosis requires the confirmation 
of the results by another quantitative method, such as Western blot.
2.4.2 Interpretation of Western blot results
Western blot methods have become very popular in diagnostic laboratories due 
to the ability to analyze several proteins simultaneously avoiding thus the preserva-
tion of large portions from an affected muscle [36, 37].
The rapid evolution of the quantitative methods has improved over time from 
the analysis of one protein to simultaneous analysis by SDS gel electrophoresis of 
several proteins with different molecular mass. Multiplex Western blot technique 
developed by Andreson [25] represented a significant improvement in muscle 
protein analysis regarding efficiency and cost. By this method, can be evaluated the 
molecular mass (normal or reduced size) and abundance of the proteins by com-
parison with controls and the use of quantitative software analysis.
Western blot has greater importance in muscle protein analysis especially in 
the differential diagnosis of muscular dystrophies (distinguish between DMD and 
BMD patients); for analysis of calpain 3 in it, there are no antibodies available for 
immunoreactions on the sections.
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2.4.2.1 Applications, utility, and importance of immunoassay methods
The immunohistochemical reactions are widely used both in the investigation 
and in the pathological diagnosis evaluations of diseases based on the antigen-
antibody reactions. The identification and localization of an antigen in a tissue or 
cells can provide valuable information, which otherwise could not be obtained by 
other methods. Because most of the antigens are usually proteins, identifications 
of abnormal expression patterns of proteins in diseased tissue are also helpful in 
differential diagnosis and detecting primary protein defect involved in the pathol-
ogy. Besides the identification of a primary defect and protein expression chances, 
immunohistochemistry is also helpful in the pharmaceutical analysis area for drug 
discovery and therapeutic drug monitoring.
2.4.3 Therapeutic drug monitoring
With knowledge advance in disease pathogenesis and the development of novel 
therapeutic strategies, there is a need to generate new treatments for specific neu-
rodegenerative disorders. In the last few years, the use of antisense oligonucleotides 
(AOs) has increased interest in the treatment of the different types of muscular 
dystrophy such as Duchenne muscular dystrophy.
Antisense oligonucleotides, a new class of the synthetic single-stranded mol-
ecules of nucleic acids as RNA or DNA, have been reported that modulate the gene 
expression and splicing process interacting with specific gene transcripts through a 
variety of mechanisms and restore the expression of functional protein [38, 39].
The quantification of protein levels after treatment will be monitored by 
the immunoassay method after administration of a specific dose of specific 
AOs. Positive results obtained in clinical trials with AOs for different diseases 
increase the interest in the clinical application of antisense strategies. However, 
more clinical trials and more data are necessary to make this strategy clinically 
available.
Difficulties, limitations, and disadvantages of immunostaining methods and 
troubleshooting are discussed further.
a. Difficulties
Although it is a simple technique, many parameters must be considered and 
optimized before. The quality of the results depends on these critical factors that 
begin from handling the specimen to tissue fixation procedure, detection system, 
staining protocol, antibody selection, and sensitivity. Also, the ability, experi-
ence, the rigor of execution of the researcher in performing the reaction, and good 
knowledge and understanding of the methodology and morphological changes in a 
specific pathology are necessary for an accurate overview of protein expression and 
interpretation of the results to avoid misinterpretation [40, 41].
b. Limitations
One of the major limitations of the immunoassays is antibody specificity. The 
nonspecific binding occurs when an antibody attaches to a cell without a specific 
epitope for that antibody. Several reasons are responsible for nonspecific binding 
such as higher concentrations of the antibody and binding by Fc segment con-
tained by most of the antibodies to Fc receptors of immune cells (e.g., neutrophils, 
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monocytes, and macrophages). The decrease of antibody concentration and the use 
of an Fc blocking reagent will minimize the nonspecific binding [42].
The nonspecific binding of the antibody can cause errors and confusion in 
the interpretation of the obtained results. To eliminate the interpretational error, 
antibody specificity controls must be introduced into the reaction to obtain reliable 
staining [43].
A limited number of available antibodies for muscle protein represent another 
limitation of this method as well as the choice of an insufficiently specific and 
sensitive antibody for the desired target. Often, the resolution microscope is a 
limitation in determining the proper intensity of the signal of the target antigen as 
well as subtle differences in protein expression level. This problem can be solved 
by confocal laser scanning microscopes, which offer a possibility to overcome this 
problem by providing images in the highest resolutions and can predict accurately 
variation in staining intensity. It must be considered that the image quality degrades 
over time.
c. Disadvantages
Both direct and indirect immunofluorescence methods have some advantages 
and disadvantages, which are presented in Table 3. Besides, these immunostaining 
methods have some disadvantages among which we mention the lack of worldwide 
standardized protocol that determines the introduction of a level of subjectivity 
both in the working procedure and in the interpretation of the obtained results. 
Once again, the experience of the personnel who work this technique is crucial.
3. Conclusion
Immunoassay methods are a powerful tool for characterization of the proteins 
regarding localization, understanding the quantitative and qualitative charac-
teristics, as well as interactions of proteins at the cellular level. The progress of 
the development of the specific antibodies, as well as improvement in image 
analysis software, leads to more sensitive and specific immunoassay methods used 
for characterization of the proteins. However, a combination of qualitative and 
quantitative methodologies offers great value for the results. Further advances in 
immunoassay methods will lead to a better understanding of the functional role 
of proteins.
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Acronyms and Abbreviations
Ag antigen
AOs antisense oligonucleotides
BMD Becker muscular dystrophy
DMD Duchenne muscular dystrophy
CMD congenital muscular dystrophy
ICW in-cell Western
IF immunofluorescence
Ig immunoglobulins
IHC immunohistochemistry
LGMD limb-girdle muscular dystrophy
MAbs monoclonal antibodies
MEB muscle-eye-brain disease
PAbs polyclonal antibodies
WB Western blot
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